Los Angeles, CA (PRWEB) July 11, 2012
The action-packed Canines for the Cure Texas Agility Shoot-out (txagilityshootout.com) is sure to get dogs howling and barking during a fun-filled competition. While dogs run through tunnels and jump over hurdles, pet owners and pet lovers alike will remember their loving dogs at the 2012 Memorial Wall presented by Elimay Supplements.
The memorial wall gives owners a chance to commemorate their dogs that passed away due to canine cancer with a donation in honor of their dog. This year however, the memory of one special dog will provide a chance for all dog owners to remember their four-legged friends.
Eli May was a dog who was very loved by her owner. As Eli May suffered, her owner cared for her, empathized with her pain and suffering, and was bereaved when she finally passed away of cancer. Elimay Supplements was founded in her honor. This year in her remembrance, all attendees will be able to post their memorials on the wall free of charge.
Christi Farley, Trial Chair and Founder of Texas Agility Shoot-Out in honor of her dog Ranger explained how the spirit of the Shoot-Out is about the wonderful bond between dogs and their owners. “The donation of the Memorial Wall by Elimay Supplements makes it possible for all competitors to participate in celebrating the lives of canine companions that have been lost to cancer as well as the growing number of survivors! Their mere presence on the wall indicates a deep bond, and as people randomly gather around the Memorial Wall, you can see owners point out their own pup on the wall and hear them proudly tell stories and anecdotes of their canine angels. It is the essence of the Memorial Wall and what brings such a sweet spirit to the Texas Agility Shoot-Out.”
One in every three dogs suffers from cancer and the Canines for the Cure Texas Agility Shoot-Out donates 100 percent of proceeds towards grants that aid canine cancer focused studies. The 2011 Shoot-Out raised $42,000 and the National Canine Cancer Foundation hopes to break the $50,000 mark in 2012.
“The Memorial Wall is very special,” said Gary Nice, Founder and President of the National Canine Cancer Foundation. “It is a time, a place, a special moment where the competitors put pictures of the sweet pups they love and say this is why I’m here. This is who I’m raising money for. It is a healing moment.”
This year, the Texas Agility Shoot Out is dedicated to Mandy, a Great Dane who at 6 years of age was taken by cancer. The 4th Annual Texas Agility Shoot-Out features several hundred talented dogs competing for fun, prizes and to beat cancer at Fort Worth's Will Rogers Coliseum.
Held on August 4, 2012 to August 5, 2012, the 4th Annual Canines for the Cure Texas Agility Shoot-Out is an exciting dog agility trial in which 100% of the profits will benefit the National Canine Cancer Foundation. Donations and profits will help fund research towards finding cures for canine cancer. In addition to 3 rings of Agility, the Shoot-Out hosts a vendor area featuring Elimay, Petco, NCCF and others. The Memorial Wall Celebration, World Famous Texas Sized Raffle will feature a stay at Hotel Palomar - a Conde' Nast "Hotel We Love" winner, gift baskets from John Paul Pet, and Modern Dog Magazine. Those who cannot make it can still support the cause by ordering an exclusive Texas Agility Shoot-out shirt online now!
“It is an honor to be part of so many people’s lives through the 2012 Memorial Wall,” said Suchet Rastogi, Director of International Business for Elimay Supplements, Inc. “We hope this gathering will be a fun and special way for pet owners to remember their dogs as well as honor the lives of those living with them. Whether their dogs are participating in the Shoot-Out or watching from the sidelines, their love and activity is an inspiration to remember our pets and help find ways to better their health.”
Non-profit corporation, The National Canine Cancer Foundation, is proactive in funding research grants that intend on conducting scientific trials to better understand canine health. A current study sponsored by Elimay Supplements is an observational study to evaluate the efficacy of supplements in affecting the overall daily health and quality of life regardless of a dog’s diagnosed health issues. For more information about the National Canine Cancer Foundation, please visit wearethecure.org.
About Elimay Supplements, Inc.
At Elimay Supplements, Inc., we understand how dogs are loved as a member of the
family. We understand the joy of their spirit, care, and company. Eli May was one such special dog whose owner wanted the best health for his beloved companion. He wished she would have a long, healthy, happy life with him.
We strive to help our animal companions have the best, most active fulfilling life with those who care for them. With our products, we aim to help dogs who are fighting abnormal cell growth to detox, better their immunity, and enhance their quality of life.
The Elimay Supplements product line includes soft fish-flavored gelatin capsules to help dogs who are fighting abnormal cell growth to detox, better their immunity, and enhance their quality of life with essential omegas and nutrients.
For more information about Elimay Supplements, please visit http://www.elimaysupplements.com.
About The National Canine Cancer Foundation
The National Canine Cancer Foundation is a nationwide, contribution funded, 501 ©(3) non-profit corporation dedicated to eliminating Cancer as a major health issue in dogs by funding grants directly to Cancer researchers who are working to save lives, find cures, better treatments and accurate, cost effective diagnostic methods in dealing with canine Cancer.
The purpose of the Foundation’s Research Grant Program is to encourage and provide grant support for basic, pre-clinical and clinical research in high impact and innovative cancer research, which is intended to develop innovative approaches to a cure, treatment, diagnosis or prevention of cancers in dogs. The program fosters collaboration between basic and clinical scientists with the intent of enhancing the transfer of basic research findings to clinical usefulness.